Biocan Novel DHPPi/L4, liofilizatas ir skiediklis injekcinei suspensijai ruošti šunims
Biocan Novel DHPPi/L4, liofilizatas ir skiediklis injekcinei suspensijai ruošti šunims
Authorised
- Leptospira kirschneri, serogroup Grippotyphosa, serovar Grippotyphosa, strain MSLB 1091, Inactivated
- Leptospira interrogans, serogroup Australis, serovar Bratislava, strain MSLB 1088, Inactivated
- Leptospira interrogans, serogroup Canicola, serovar Canicola, strain MSLB 1090, Inactivated
- Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain MSLB 1089, Inactivated
- Canine parainfluenza virus, strain CPiV-2-Bio 15, Live
- Canine parvovirus 2b, strain CPV-2b Bio 12/B, Live
- Canine adenovirus 2, strain CAV-2-Bio 13, Live
- Canine distemper virus, strain CDV Bio 11/A, Live
Product identification
Medicine name:
Biocan Novel DHPPi/L4, liofilizatas ir skiediklis injekcinei suspensijai ruošti šunims
Active substance:
- Leptospira kirschneri, serogroup Grippotyphosa, serovar Grippotyphosa, strain MSLB 1091, Inactivated
- Leptospira interrogans, serogroup Australis, serovar Bratislava, strain MSLB 1088, Inactivated
- Leptospira interrogans, serogroup Canicola, serovar Canicola, strain MSLB 1090, Inactivated
- Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain MSLB 1089, Inactivated
- Canine parainfluenza virus, strain CPiV-2-Bio 15, Live
- Canine parvovirus 2b, strain CPV-2b Bio 12/B, Live
- Canine adenovirus 2, strain CAV-2-Bio 13, Live
- Canine distemper virus, strain CDV Bio 11/A, Live
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Canine distemper virus, strain CDV Bio 11/A, Live5.10log10 tissue culture infective dose 501.00Dose
-
Canine adenovirus 2, strain CAV-2-Bio 13, Live5.30log10 tissue culture infective dose 501.00Dose
-
Canine parvovirus 2b, strain CPV-2b Bio 12/B, Live6.60log10 tissue culture infective dose 501.00Dose
-
Canine parainfluenza virus, strain CPiV-2-Bio 15, Live5.10log10 tissue culture infective dose 501.00Dose
-
Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain MSLB 1089, Inactivated51.00Antibody microagglutination-lytic reaction1.00Dose
-
Leptospira interrogans, serogroup Canicola, serovar Canicola, strain MSLB 1090, Inactivated51.00Antibody microagglutination-lytic reaction1.00Dose
-
Leptospira interrogans, serogroup Australis, serovar Bratislava, strain MSLB 1088, Inactivated51.00Antibody microagglutination-lytic reaction1.00Dose
-
Leptospira kirschneri, serogroup Grippotyphosa, serovar Grippotyphosa, strain MSLB 1091, Inactivated40.00Antibody microagglutination-lytic reaction1.00Dose
Pharmaceutical form:
-
Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AI02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Lithuania
Additional information
Entitlement type:
-
Parallel Trade Approval
Marketing authorisation date:
Responsible authority:
- State Food And Veterinary Service
Authorisation number:
- B1-994
Parallel trade in reference of:
Parallel trade of:
Source wholesaler:
- Bertas Nams SIA
Destination wholesaler:
- Vetfarmas UAB
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?: